Same Indication

Ipilimumab vs Sumatriptan

Ipilimumab vs Sumatriptan: Overview

This comparison examines the pharmacological differences between Ipilimumab and Sumatriptan.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Sumatriptan: Selective 5-HT1B/1D receptor agonist.

Pharmacokinetics

Half-life: Ipilimumab — 14.7 days; Sumatriptan — 2.5 hours.

Chemical Properties

Molecular Formula: Sumatriptan — C14H21N3O2S.

Molecular Weight: Sumatriptan — 295.4020 g/mol.

Type: Ipilimumab — Antibody; Sumatriptan — Small molecule.